Literature DB >> 33913198

Role of TCF-1 in differentiation, exhaustion, and memory of CD8+ T cells: A review.

Jiaxue Zhang1, Tong Lyu2, Yaming Cao2, Hui Feng2.   

Abstract

T cell factor-1 (TCF-1) (encoded by the TCF7 gene) is a transcription factor that plays important role during the T cell development and differentiation for T cell to exercise its functions including producing memory T cells. Not only TCF-1 can modulate the T cell development but also exerts various effects on the differentiation and function of mature CD8+ T cells. In addition, it drives the production and maintenance of the immune response of CD8+ T cells after PD-1 checkpoint blockade therapy. TCF-1 can serve as a potential target of immunotherapy and may provide promising novel treatment strategies for patients with cancer and infections. Moreover, TCF-1 is a potential biomarker of CD8+ T cell functionality to predict the efficacy of immunotherapy in fighting against cancer and infections. Herein, we summarize the role of TCF-1 in T cell development and its applications in the treatment of cancer and infectious diseases.
© 2021 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  CD8+ T cells; TCF-1; cancer; exhaustion; immune memory; viral Infection

Mesh:

Substances:

Year:  2021        PMID: 33913198     DOI: 10.1096/fj.202002566R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  6 in total

1.  Single-Cell RNA Sequencing of Peripheral Blood Mononuclear Cells From Acute Myocardial Infarction.

Authors:  Jun Qian; Yanhua Gao; Yan Lai; Zi Ye; Yian Yao; Keke Ding; Jing Tong; Hao Lin; Guoqi Zhu; Yunan Yu; Haoran Ding; Deqiang Yuan; Jiapeng Chu; Fei Chen; Xuebo Liu
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

Review 2.  Immunometabolism - The Role of Branched-Chain Amino Acids.

Authors:  Berkay Yahsi; Gurcan Gunaydin
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

3.  Tumor Expression Quantitative Trait Methylation Screening Reveals Distinct CpG Panels for Deconvolving Cancer Immune Signatures.

Authors:  Xiaoqing Yu; Ling Cen; Y Ann Chen; Joseph Markowitz; Timothy I Shaw; Kenneth Y Tsai; Jose R Conejo-Garcia; Xuefeng Wang
Journal:  Cancer Res       Date:  2022-05-03       Impact factor: 13.312

4.  CDK4/6 blockade provides an alternative approach for treatment of mismatch-repair deficient tumors.

Authors:  Inken Salewski; Julia Henne; Leonie Engster; Paula Krone; Bjoern Schneider; Caterina Redwanz; Heiko Lemcke; Larissa Henze; Christian Junghanss; Claudia Maletzki
Journal:  Oncoimmunology       Date:  2022-07-11       Impact factor: 7.723

Review 5.  Checkpoint Inhibition in Bladder Cancer: Clinical Expectations, Current Evidence, and Proposal of Future Strategies Based on a Tumor-Specific Immunobiological Approach.

Authors:  Mariangela Mancini; Marialaura Righetto; Elfriede Noessner
Journal:  Cancers (Basel)       Date:  2021-11-29       Impact factor: 6.639

Review 6.  Adaptive Immune Responses, Immune Escape and Immune-Mediated Pathogenesis during HDV Infection.

Authors:  Valerie Oberhardt; Maike Hofmann; Robert Thimme; Christoph Neumann-Haefelin
Journal:  Viruses       Date:  2022-01-20       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.